Axcelis Technologies, Inc. ist eine Aktie aus dem Premium-Bereich von aktien.guide. Bitte anmelden, um einen Alarm für Axcelis Technologies, Inc. zu aktivieren.
Kostenlos registrieren
Bitte registriere Dich kostenlos, um Axcelis Technologies, Inc. zu Deinem Portfolio hinzuzufügen.
Axcelis Technologies stands to benefit from the semiconductor industry's demand for advanced ion implantation, driven by smaller node geometries and new device architectures. Despite recent cyclical downturns impacting revenue and margins, Axcelis maintains pricing discipline and a resilient service business to buffer volatility. Axcelis' deep specialization in ion implantation gives it a techn...
Semiconductor fabrication equipment is crucial for future tech growth, including EVs and AI datacenters, which require increased production of specialized chips. Axcelis Technologies, despite a temporary dip in orders, is vital for global semiconductor production with its innovative ion implant systems. Axcelis shares have dropped from extremely overvalued in 2023 to undervalued territory in 20...
A bottom-line beat in its inaugural quarter of 2025 was the factor that drove Axcelis Technologies's (ACLS -2.04%) share price higher over the trailing five trading days. The semiconductor equipment specialist enjoyed a 10% gain over the course of the week, according to data compiled by S&P Global Market Intelligence.
BEVERLY, Mass. , May 7, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The 53rd Annual J.P.
Axcelis Technologies, Inc. (NASDAQ:ACLS ) Q1 2025 Results Conference Call May 6, 2025 8:30 AM ET Company Participants David Ryzhik - SVP, IR and Corporate Strategy Russell Low - President and CEO Jamie Coogan - EVP and CFO Conference Call Participants Craig Ellis - B. Riley Securities Jed Dorsheimer - William Blair Charles Shi - Needham & Company Tom Diffely - D.A.
Q1 Highlights: Revenue of $192.6 million GAAP Gross Margin of 46.1%, and Non-GAAP Gross Margin of 46.4% GAAP Operating Margin of 15.1% and Non-GAAP Operating Margin of 18.3% GAAP Diluted earnings per share of $0.88, and Non-GAAP Diluted earnings per share of $1.04 BEVERLY, Mass. , May 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fir...
BEVERLY, Mass. , April 24, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be a sponsor for the Advanced Semiconductor Manufacturing Conference (ASMC) on May 5-8, 2025, at the Hilton Albany, in Albany, New York.
BEVERLY, Mass. , April 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter 2025 before the opening of the market on Tuesday, May 6, 2025.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.